Venkatesan Jay Insider Trades

Insider Trading History

Track insider trading activity for Venkatesan Jay. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Serina Therapeutics
Serina Therapeutics SER
Director
Holding Value $14.7k 7,553 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.7k 7,553 shares
$1.94
$1.95
Serina Therapeutics
Serina Therapeutics SER
Director
Holding Value $19.5k 10,000 shares
Last Trade
Nov 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1k 10,000 shares
$3.91
$1.95
Elicio Therapeutics
Elicio Therapeutics ELTX
Director
Holding Value $32.5k 7,900 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.1k 7,900 shares
$5.84
$4.11
Serina Therapeutics
Serina Therapeutics SER
Director
Holding Value $188k 96,525 shares
Last Trade
Apr 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 96,525 shares
$5.18
$1.95
Serina Therapeutics
Serina Therapeutics SER
Director
Holding Value $78k 40,000 shares
Last Trade
Feb 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 40,000 shares
$4.60
$1.95
Elicio Therapeutics
Elicio Therapeutics ELTX
Director
Holding Value $0 0 shares
Last Trade
Nov 26, 2024 Sale (In The Money)Reported as In The Money on SEC Form 4.
$244k 50,000 shares
$4.88
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
Director
Holding Value $738k 179,581 shares
Last Trade
Nov 26, 2024 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$244k 50,000 shares
$4.88
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
Director
Holding Value $16.9k 4,100 shares
Last Trade
Nov 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21k 4,100 shares
$5.12
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
Director
Holding Value $206k 50,000 shares
Last Trade
Jun 28, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$206k 50,000 shares
$4.11
$4.11
Angion Biomedica
Angion Biomedica ANGN
Director
Holding Value $4.1k 4,100 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 4,100 shares
$100.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
Director
Holding Value $16.9k 4,100 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.9k 4,100 shares
$8.26
$4.11
Alpine Immune Sciences
Alpine Immune Sciences ALPN
Director
Holding Value $4.55M 70,000 shares
Last Trade
Jul 15, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$181k 20,063 shares
$9.00
$64.97
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $1.89M 1,891,947 shares
Last Trade
May 25, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.43M 11,313 shares
$126.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
director, officer
Holding Value $7.78M 1,891,947 shares
Last Trade
May 25, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.43M 11,313 shares
$126.00
$4.11
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $1.72M 1,721,457 shares
Last Trade
May 24, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.96M 32,200 shares
$123.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
President And Chief Executive Officer And Director
Holding Value $7.08M 1,721,457 shares
Last Trade
May 24, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.96M 32,200 shares
$123.00
$4.11
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $1.69M 1,689,257 shares
Last Trade
May 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.4M 50,000 shares
$128.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
President And Chief Executive Officer And Director
Holding Value $6.94M 1,689,257 shares
Last Trade
May 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.4M 50,000 shares
$128.00
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
President And Chief Executive Officer
Holding Value $3.12M 760,000 shares
Last Trade
Mar 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147M 760,000 shares
$194.00
$4.11
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $760k 760,000 shares
Last Trade
Mar 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147M 760,000 shares
$194.00
$1.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up